Serum effects confound the neuroleptic radioreceptor assay
- 1 March 1984
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 34 (11), 1057-1064
- https://doi.org/10.1016/0024-3205(84)90019-5
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Serum concentrations of thioridazine, its major metabolites and serum neuroleptic‐like activities in schizophrenics with and without tardive dyskinesiaActa Psychiatrica Scandinavica, 1982
- Neuroleptic Drug Level Monitoring in PsychiatryTherapeutic Drug Monitoring, 1982
- Influence of Blood Sampling Methods on Dopamine-Receptor-Blocking Activities as Determined by a Radioreceptor AssayTherapeutic Drug Monitoring, 1982
- Disparate Serum Thioridazine Concentrations: Liquid Chromatography versus Radioreceptor AssayActa Pharmacologica et Toxicologica, 1982
- Neuroleptic Serum Levels Measured by Radioreceptor Assay and Clinical Response in Schizophrenic PatientsJournal of Nervous & Mental Disease, 1981
- Neuroleptic blood levels and therapeutic effectPsychopharmacology, 1980
- Clinical use of the radioreceptor assay for neurolepticsPsychiatry Research, 1980
- Low neuroleptic serum levels in patients receiving fluphenazine decanoateAmerican Journal of Psychiatry, 1980
- Antischizophrenic drugs: Differential plasma protein binding and therapeutic activityLife Sciences, 1979
- A simple and sensitive radioreceptor assay for antischizophrenic drugs in bloodNature, 1977